FDA grants RMAT designation to Tenaya's TN-401 heart gene therapy
Go back to FDA grants RMAT designation to Tenaya's TN-401 heart gene therapy| (NASDAQ: TNYA) | Delayed: 0.38 -0.01 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $ | |||
| Open | $0.39 | 52 Week Low | $ | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $ | |||
| Volume | 562,517 | |||||



